• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

草药治疗 COVID-19 患儿:指南综述。

Herbal medicine for treatment of children diagnosed with COVID-19: A review of guidelines.

机构信息

Clinical Medicine Division, Korea Institute of Oriental Medicine, Daejeon, South Korea; Korean Convergence Medicine, University of Science and Technology, Daejeon, South Korea.

Herbal Medicine Research Division, Korea Institute of Oriental Medicine, Daejeon, South Korea.

出版信息

Complement Ther Clin Pract. 2020 May;39:101174. doi: 10.1016/j.ctcp.2020.101174. Epub 2020 Apr 12.

DOI:10.1016/j.ctcp.2020.101174
PMID:32379639
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7152923/
Abstract

This review aimed to summarize and analyze the pattern identification (PI), herbal formulae, and composition of herbs provided by recent guidelines for the treatment of pediatric COVID-19. Seven data sources were reviewed until March 25, 2020. We analyzed the herbal formulae included in the guidelines and performed a network analysis to identify the frequency of herbs recommended in the herbal formulae. All 3 guidelines were provincial guidelines from China. Our results showed that there were 4 stages, 12 PIs, and 13 herbal formulae recommended by the provincial guidelines. These herbal formulae included a total of 56 herbs. Based on our network analysis, Scutellariae Radix was paired with Artemisiae Annuae Herba in one cluster. In another cluster, Armeniacae Semen was paired with Coicis Semen and Ephedrae Herba was paired with Gypsum Fibrosum. This review serves as a reference for the use of traditional medicine in the treatment of pediatric COVID-19.

摘要

本次综述旨在总结和分析最近针对小儿 COVID-19 治疗的指南中提出的模式识别 (PI)、方剂和草药组成。我们对截至 2020 年 3 月 25 日的 7 个数据源进行了审查。我们分析了指南中包含的方剂,并进行了网络分析以确定推荐方剂中草药的使用频率。所有 3 个指南均为中国省级指南。研究结果表明,省级指南中提出了 4 个阶段、12 个 PI 和 13 个方剂。这些方剂共包含 56 种草药。基于网络分析,黄芩与青蒿在一个聚类中配对,杏仁与薏苡仁配对,麻黄与石膏配对。本综述为小儿 COVID-19 治疗中使用传统医学提供了参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400c/7152923/390ce31d9e39/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400c/7152923/390ce31d9e39/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400c/7152923/390ce31d9e39/gr1_lrg.jpg

相似文献

1
Herbal medicine for treatment of children diagnosed with COVID-19: A review of guidelines.草药治疗 COVID-19 患儿:指南综述。
Complement Ther Clin Pract. 2020 May;39:101174. doi: 10.1016/j.ctcp.2020.101174. Epub 2020 Apr 12.
2
[Study on medication regularity of traditional Chinese medicine in treatment of COVID-19 based on data mining].基于数据挖掘的中医治疗新型冠状病毒肺炎用药规律研究
Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(6):1248-1252. doi: 10.19540/j.cnki.cjcmm.20200220.502.
3
Clinical practice guidelines and experts' consensuses of traditional Chinese herbal medicine for novel coronavirus (COVID-19): protocol of a systematic review.临床实践指南和传统中药专家共识治疗新型冠状病毒(COVID-19):系统评价方案。
Syst Rev. 2020 Aug 3;9(1):170. doi: 10.1186/s13643-020-01432-4.
4
[Analysis of medication regularity and pharmacodynamic characteristics of traditional Chinese medicine treatment in 444 severe cases of COVID-19].444例新冠肺炎重症病例中医治疗用药规律及药效学特征分析
Zhongguo Zhong Yao Za Zhi. 2020 Jul;45(13):3007-3012. doi: 10.19540/j.cnki.cjcmm.20200427.501.
5
[Analysis of traditional Chinese medicine from patent information sharing platform of coronavirus disease 2019 (COVID-19)].[基于2019冠状病毒病(COVID-19)专利信息共享平台的中医药分析]
Zhongguo Zhong Yao Za Zhi. 2020 Jul;45(13):3001-3006. doi: 10.19540/j.cnki.cjcmm.20200330.501.
6
Databases for facilitating mechanistic investigations of traditional Chinese medicines against COVID-19.促进中药抗COVID-19机制研究的数据库
Pharmacol Res. 2020 Sep;159:104989. doi: 10.1016/j.phrs.2020.104989. Epub 2020 Jun 2.
7
East meets West in COVID-19 therapeutics.在新冠病毒治疗中,东西方相遇了。
Pharmacol Res. 2020 Sep;159:105008. doi: 10.1016/j.phrs.2020.105008. Epub 2020 Jun 9.
8
Medication Rule Analysis of the Diagnosis and Treatment Programs of Chinese Medicine for the Prevention and Treatment of COVID-19 in China.中医药防治新冠肺炎诊疗方案用药规律分析。
Chin J Integr Med. 2022 Sep;28(9):779-784. doi: 10.1007/s11655-021-2880-1. Epub 2022 Jan 13.
9
A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19).关于2019冠状病毒病(COVID-19)传统医学治疗选择的叙述性文献综述。
Complement Ther Clin Pract. 2020 Aug;40:101214. doi: 10.1016/j.ctcp.2020.101214. Epub 2020 Jun 17.
10
[Analysis of property and efficacy of traditional Chinese medicine in staging revention and treatment of coronavirus disease 2019].[中医药在新型冠状病毒肺炎分期防治中的特性与疗效分析]
Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(6):1253-1258. doi: 10.19540/j.cnki.cjcmm.20200225.501.

引用本文的文献

1
Beneficial Bacterial Modulation by Gypsum Fibrosum and Terra Flava Usta in Gut Microbiota.石膏与伏龙肝对肠道微生物群的有益细菌调节作用
Chin J Integr Med. 2025 Apr 15. doi: 10.1007/s11655-025-4129-x.
2
Molecular Mechanism of the Asarum-Angelica Drug Pair in the Treatment of Periodontitis Based on Network Pharmacology and Experimental Verification.基于网络药理学和实验验证的细辛-当归药对治疗牙周炎的分子机制
Int J Mol Sci. 2023 Dec 12;24(24):17389. doi: 10.3390/ijms242417389.
3
Whole-genome sequencing in medicinal plants: current progress and prospect.

本文引用的文献

1
Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines.用于治疗新型冠状病毒肺炎的草药医学与辨证论治:指南快速回顾
Integr Med Res. 2020 Jun;9(2):100407. doi: 10.1016/j.imr.2020.100407. Epub 2020 Mar 29.
2
SARS-CoV-2 Infection in Children.儿童感染新型冠状病毒2型
N Engl J Med. 2020 Apr 23;382(17):1663-1665. doi: 10.1056/NEJMc2005073. Epub 2020 Mar 18.
3
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.
药用植物的全基因组测序:当前进展与展望
Sci China Life Sci. 2024 Feb;67(2):258-273. doi: 10.1007/s11427-022-2375-y. Epub 2023 Oct 12.
4
Emergency Protective Measures and Strategies of COVID-19: From Lifestyle to Traditional Chinese Medicine.新型冠状病毒肺炎的应急防护措施与策略:从生活方式到中医药
Clin Complement Med Pharmacol. 2023 Sep;3(3):100089. doi: 10.1016/j.ccmp.2023.100089. Epub 2023 Apr 6.
5
Ephedrae Herba: A Review of Its Phytochemistry, Pharmacology, Clinical Application, and Alkaloid Toxicity.麻黄:本草考证、化学成分、药理作用、临床应用及生物碱毒性研究进展。
Molecules. 2023 Jan 9;28(2):663. doi: 10.3390/molecules28020663.
6
Broad-spectrum antiviral activity of Spatholobus suberectus Dunn against SARS-CoV-2, SARS-CoV-1, H5N1, and other enveloped viruses.鸡血藤对 SARS-CoV-2、SARS-CoV-1、H5N1 及其他包膜病毒具有广谱抗病毒活性。
Phytother Res. 2022 Aug;36(8):3232-3247. doi: 10.1002/ptr.7452.
7
Prospective Medicinal Plants and Their Phytochemicals Shielding Autoimmune and Cancer Patients Against the SARS-CoV-2 Pandemic: A Special Focus on Matcha.前瞻性药用植物及其植物化学物质保护自身免疫性疾病患者和癌症患者免受新冠疫情影响:特别关注抹茶。
Front Oncol. 2022 May 18;12:837408. doi: 10.3389/fonc.2022.837408. eCollection 2022.
8
Nucleic Acids as Biotools at the Interface between Chemistry and Nanomedicine in the COVID-19 Era.在 COVID-19 时代,核酸作为化学与纳米医学交叉界面的生物工具。
Int J Mol Sci. 2022 Apr 14;23(8):4359. doi: 10.3390/ijms23084359.
9
GRADE Methods in traditional medicine.传统医学中的GRADE方法。
Integr Med Res. 2022 Jun;11(2):100836. doi: 10.1016/j.imr.2022.100836. Epub 2022 Jan 26.
10
COVID-19 treatment in children: A systematic review and meta-analysis.儿童新冠病毒肺炎的治疗:一项系统评价与荟萃分析
J Family Med Prim Care. 2021 Sep;10(9):3292-3302. doi: 10.4103/jfmpc.jfmpc_2583_20. Epub 2021 Sep 30.
中国2019年冠状病毒病(COVID-19)疫情的特征及重要经验教训:来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
4
Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs.中医可否用于预防 2019 年冠状病毒病(COVID-19)?对历史经典、研究证据和当前预防方案的回顾。
Chin J Integr Med. 2020 Apr;26(4):243-250. doi: 10.1007/s11655-020-3192-6. Epub 2020 Feb 17.
5
Characteristics of traditional Chinese medicine use in children with asthma: a nationwide population-based study.中医药治疗儿童哮喘的特点:一项全国性基于人群的研究。
Allergy. 2013 Dec;68(12):1610-3. doi: 10.1111/all.12273. Epub 2013 Oct 14.
6
Traditional Chinese herbal medicine as a source of molecules with antiviral activity.传统中药作为具有抗病毒活性的分子来源。
Antiviral Res. 2013 Jan;97(1):1-9. doi: 10.1016/j.antiviral.2012.10.006. Epub 2012 Nov 12.
7
Mechanism by which ma-xing-shi-gan-tang inhibits the entry of influenza virus.麻杏石甘汤抑制流感病毒进入的机制。
J Ethnopharmacol. 2012 Aug 30;143(1):57-67. doi: 10.1016/j.jep.2012.05.061. Epub 2012 Jun 16.
8
Antiasthmatic activity and selective inhibition of type 2 helper T cell response by aqueous extract of semen armeniacae amarum.苦杏仁水提取物的抗哮喘活性及对2型辅助性T细胞反应的选择性抑制作用。
Immunopharmacol Immunotoxicol. 2006;28(2):213-25. doi: 10.1080/08923970600815253.
9
The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations.成人社区获得性肺炎管理的日本呼吸学会指南:更新与新建议
Intern Med. 2006;45(7):419-28. doi: 10.2169/internalmedicine.45.1691. Epub 2006 May 1.
10
Identification of natural compounds with antiviral activities against SARS-associated coronavirus.鉴定具有抗严重急性呼吸综合征相关冠状病毒抗病毒活性的天然化合物。
Antiviral Res. 2005 Jul;67(1):18-23. doi: 10.1016/j.antiviral.2005.02.007.